Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BIRD NASDAQ:JRSH NASDAQ:PMNT NASDAQ:SILO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBIRDAllbirds$5.12-7.1%$5.54$2.15▼$24.31$48.52M2.563.91 million shs1.62 million shsJRSHJerash Holdings (US)$4.72+1.9%$3.51$2.85▼$5.47$58.80M1.112.16 million shs295,643 shsPMNTPerfect Moment$0.08-20.0%$0.24$0.07▼$0.72$4.80M-1.926.12 million shs4.96 million shsSILOSilo Pharma$6.24+3.8%$6.42$3.32▼$15.15$6.52M0.6335,935 shs182,344 shsThe 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBIRDAllbirds-7.08%+29.95%+33.33%+43.42%-48.28%JRSHJerash Holdings (US)+1.94%+12.38%+44.79%+57.33%+46.58%PMNTPerfect Moment-20.02%-49.00%-63.92%-59.25%-81.39%SILOSilo Pharma+3.83%-0.16%+6.39%+9.44%-31.06%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBIRDAllbirds$5.12-7.1%$5.54$2.15▼$24.31$48.52M2.563.91 million shs1.62 million shsJRSHJerash Holdings (US)$4.72+1.9%$3.51$2.85▼$5.47$58.80M1.112.16 million shs295,643 shsPMNTPerfect Moment$0.08-20.0%$0.24$0.07▼$0.72$4.80M-1.926.12 million shs4.96 million shsSILOSilo Pharma$6.24+3.8%$6.42$3.32▼$15.15$6.52M0.6335,935 shs182,344 shsThe 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBIRDAllbirds-7.08%+29.95%+33.33%+43.42%-48.28%JRSHJerash Holdings (US)+1.94%+12.38%+44.79%+57.33%+46.58%PMNTPerfect Moment-20.02%-49.00%-63.92%-59.25%-81.39%SILOSilo Pharma+3.83%-0.16%+6.39%+9.44%-31.06%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBIRDAllbirds 1.67Reduce$8.0056.25% UpsideJRSHJerash Holdings (US) 2.50Moderate Buy$5.005.93% UpsidePMNTPerfect Moment 3.00Buy$1.501,731.50% UpsideSILOSilo Pharma 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest BIRD, JRSH, SILO, and PMNT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/17/2026JRSHJerash Holdings (US) Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold (C) ➝ Hold (C+)6/16/2026JRSHJerash Holdings (US) DA DavidsonSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$5.006/11/2026SILOSilo Pharma Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)6/1/2026BIRDAllbirds Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/27/2026SILOSilo Pharma Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/1/2026BIRDAllbirds Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)4/24/2026SILOSilo Pharma Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/21/2026JRSHJerash Holdings (US) Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)(Data available from 6/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBIRDAllbirds$152.47M0.30N/AN/A$4.12 per share1.24JRSHJerash Holdings (US)$166.26M0.36$0.58 per share8.17$5.11 per share0.92PMNTPerfect Moment$22.93M0.17N/AN/A$0.05 per share1.64SILOSilo Pharma$70K96.27N/AN/A$7.10 per share0.88Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBIRDAllbirds-$77.28M-$9.12N/AN/AN/A-53.36%-173.54%-67.54%8/6/2026 (Estimated)JRSHJerash Holdings (US)$3.54M$0.2816.86N/AN/A2.13%5.57%4.18%8/11/2026 (Estimated)PMNTPerfect Moment-$8.72M-$0.72N/AN/AN/A-67.38%-513.83%-119.38%N/ASILOSilo Pharma-$4.23M-$6.45N/AN/AN/A-6,726.39%-88.40%-70.03%9/2/2026 (Estimated)Latest BIRD, JRSH, SILO, and PMNT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/1/2026Q4 2026JRSHJerash Holdings (US)-$0.01N/AN/AN/A$36.20 millionN/A6/15/2026Q4 2026JRSHJerash Holdings (US)-$0.01$0.12+$0.13$0.12$36.20 million$42.90 million4/20/2026Q4 2025BIRDAllbirdsN/A-$2.37N/A-$2.37N/A$22.32 million3/31/2026Q4 2025BIRDAllbirds-$2.25-$2.34-$0.09-$2.34$56.31 million$47.68 million3/27/2026Q4 2025SILOSilo PharmaN/A$0.45N/AN/AN/A$0.02 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBIRDAllbirdsN/AN/AN/AN/AN/AJRSHJerash Holdings (US)$0.204.24%N/A71.43%N/APMNTPerfect MomentN/AN/AN/AN/AN/ASILOSilo PharmaN/AN/AN/AN/AN/ALatest BIRD, JRSH, SILO, and PMNT DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/4/2026JRSHJerash Holdings (US)quarterly$0.056.04%5/14/20265/14/20265/21/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBIRDAllbirds1.071.590.68JRSHJerash Holdings (US)0.042.701.51PMNTPerfect MomentN/A1.010.70SILOSilo PharmaN/A9.659.65Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBIRDAllbirds44.07%JRSHJerash Holdings (US)3.39%PMNTPerfect Moment23.00%SILOSilo Pharma5.58%Insider OwnershipCompanyInsider OwnershipBIRDAllbirds30.67%JRSHJerash Holdings (US)42.70%PMNTPerfect Moment22.22%SILOSilo Pharma2.22%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBIRDAllbirds7108.81 million6.11 millionNot OptionableJRSHJerash Holdings (US)6,00012.70 million7.28 millionNot OptionablePMNTPerfect Moment3146.87 millionN/AN/ASILOSilo Pharma21.08 million1.06 millionNot OptionableBIRD, JRSH, SILO, and PMNT HeadlinesRecent News About These CompaniesSilo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical TrialJune 23 at 8:17 AM | globenewswire.comSilo Pharma Regains Compliance With Nasdaq Minimum Bid Price RequirementJune 18, 2026 | quiverquant.comQSilo Pharma Regains Compliance with Nasdaq Minimum Bid Price RequirementJune 18, 2026 | globenewswire.comSilo Pharma Implements Reverse Stock Split and Restructures CapitalJune 3, 2026 | tipranks.comSilo Pharma Announces 1-for-15 Reverse Stock SplitJune 2, 2026 | theglobeandmail.comSilo Pharma Inc.May 15, 2026 | marketwatch.comSilo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain InjuryMay 7, 2026 | globenewswire.comSilo Pharma, Inc.: Silo Pharma's PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSDApril 30, 2026 | finanznachrichten.deSilo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSDApril 30, 2026 | markets.businessinsider.comSilo Pharma's PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSDApril 29, 2026 | globenewswire.comSilo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, QwikagentsApril 22, 2026 | globenewswire.comSilo Pharma, Inc.: Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon ...April 20, 2026 | finanznachrichten.deSilo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon PsychedelicsApril 20, 2026 | markets.businessinsider.comSilo Pharma (SILO) Stock Rockets Nearly 50% on European PTSD Patent Approval SignalApril 8, 2026 | blockonomi.comSilo Pharma Rallies After Securing Key Patent AllowanceApril 7, 2026 | benzinga.comStock Market Today: Dow, S&P 500 Futures Rise Ahead Of Trump's 'Power Plant Day' Deadline—UnitedHealth, Silo Pharma, Phillips 66 In FocusApril 7, 2026 | benzinga.comSilo Pharma Receives European Patent Allowance for Licensed Novel PTSD Prevention TherapyApril 6, 2026 | globenewswire.comSilo Pharma's Strategic Path Forward After Fiscal 2025March 7, 2026 | aktiencheck.deASilo Pharma stock surges on $1M share buyback programFebruary 23, 2026 | in.investing.comSilo Pharma Announces Share Buyback ProgramFebruary 23, 2026 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 20265 Stocks Winning the AI Race While Everyone Watches NVIDIABy Bridget Bennett | May 26, 2026AST SpaceMobile Announces Launch Date for Its Next 3 BlueBird SatellitesBy Jessica Mitacek | June 16, 2026AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in FocusBy Jessica Mitacek | May 26, 2026AST SpaceMobile’s SpaceX Catalyst Could Come With a Volatility WarningBy Jessica Mitacek | June 10, 2026BIRD, JRSH, SILO, and PMNT Company DescriptionsAllbirds NASDAQ:BIRD$5.12 -0.39 (-7.08%) Closing price 06/23/2026 04:00 PM EasternExtended Trading$5.32 +0.20 (+3.91%) As of 05:48 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Allbirds, Inc. manufactures and sells footwear and apparel products for men and women in the United States and internationally. The company offers a range of lifestyle and performance shoes; and apparel, including classic tees and sweats, socks, and underwear. It sells its products through its retail stores, as well as online. The company was formerly known as Bozz, Inc. and changed its name to Allbirds, Inc. in December 2015. Allbirds, Inc. was incorporated in 2015 and is headquartered in San Francisco, California.Jerash Holdings (US) NASDAQ:JRSH$4.72 +0.09 (+1.94%) Closing price 06/23/2026 04:00 PM EasternExtended Trading$4.55 -0.17 (-3.58%) As of 05:47 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Jerash Holdings (US), Inc., through its subsidiaries, manufactures and exports customized and ready-made sport and outerwear. The company offers t-shirts; jackets and pullover; pants and shorts; crew neck, polo shirts, and tank tops made from knitted fabric, as well as personal protective equipment. It serves various brand-name retailers in the United States, Hong Kong, Jordan, and internationally. The company was incorporated in 2016 and is headquartered in Fairfield, New Jersey.Perfect Moment NASDAQ:PMNT$0.08 -0.02 (-20.02%) As of 06/23/2026 03:57 PM EasternPerfect Moment Ltd., together with its subsidiaries, owns and operates a fashion brand that offers ski, surf, and activewear collections under the brand name of Perfect Moment. It offers skiwear, outerwear, swimwear and activewear for women, men, and children. The company sells its collections directly to customers through e-commerce and to wholesale accounts, as well as through other sales partnerships. Perfect Moment Ltd. was founded in 1984 and is based in London, the United Kingdom.Silo Pharma NASDAQ:SILO$6.24 +0.23 (+3.83%) Closing price 06/23/2026 04:00 PM EasternExtended Trading$6.20 -0.04 (-0.63%) As of 05:27 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. It is also developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning These AI Stocks Have Insider Selling, But Buyers Still Have a Reason to Stay Apple’s Intel Deal Arrives at the Right Time for Its Stock Micron’s Sudden Plunge May Be an AI Buying Chance Amazon’s Pullback Deepens as a New FTC Risk Hits the Stock The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch. How Does D-Wave's New Simulator Change the Quantum Computing Landscape? How Intel Is Packaging the Future of American Chips Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
